Biocon Q4 profit drops 57%, but biosimilars business shines
Published on: May 8, 2026, 11:12 a.m. | Source: The Hindu Business Line
Biocon's Q4 profit drops 57% due to exceptional items, but biosimilars and generics segments show strong growth.
Build trust and reach more donors—FreeNGO creates powerful websites tailored for your cause.
Published on: May 8, 2026, 11:12 a.m. | Source: The Hindu Business Line
Biocon's Q4 profit drops 57% due to exceptional items, but biosimilars and generics segments show strong growth.
Come experience unforgettable flavors at Jayraj Restobar!
Check Now